Castle Creek Biosciences Expands its Innovative Gene Therapy Platform for Rare Genetic Connective Tissue Disorders through Research Collaboration with Mayo Clinic

Castle Creek Biosciences, Inc. announces research collaboration with Mayo Clinic.

Article from PR Newswire